Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)
Clinical trial NCT03527147 · COMPLETED
Trial details
- NCT number
- NCT03527147
- Sponsor
- Acerta Pharma BV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-19
- Primary completion
- 2021-03-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.